Among infectious diseases, tuberculosis is the leading cause of death, kill
ing around 3 million people each year. Most cases occur in young adults but
it is also a major cause of illness and death in children. The problem has
been exacerbated in recent years by the HIV pandemic and by the emergence
of multidrug resistance. Go-infection with HIV greatly enhances the risk of
overt tuberculosis and in 1999 it is expected that tuberculosis will accou
nt for 30% of the predicted 2.5 million AIDS-related deaths, By inducing cl
inically and radiologically atypical forms of tuberculosis, and by increasi
ng pressure on diagnostic facilities by sheer numbers, serious diagnostic d
ifficulties are increasingly occurring in both adults and children in the t
ropics. Ar the present time, 2% of all cases of tuberculosis are multidrug
resistant but, as the treatment of such cases is often grossly inadequate i
n many tropical countries, their frequency will doubtless grow. There are n
o simple solutions to the global emergency of tuberculosis: clearly there i
s a need for better use of available control measures but there is also a n
eed to reach a much clearer understanding of the underlying immune phenomen
a in this disease so as to develop more effective vaccines and therapeutic
agents. Finally, it cannot be ignored that tuberculosis is a disease of pov
erty-95% of cases and 98% of deaths due to it occur in the developing natio
ns-and thus a major control measure is a resolution of the gross inequities
in health care provision both between and within nations.